Zepbound (tirzepatide) injection, for subcutaneous use: Full prescribing information (NDA 217806, Orig1s020)
Both oral and injection GLP-1 medications demonstrate clinical efficacy for weight management and blood sugar control, but they differ in bioavailability, absorption capacity, and individual metabolic response
Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (STEP 4) Wadden et al
Whether managing GLP-1 side effects, staying consistent during busy seasons or holidays, rebuilding routines after a setback, or celebrating progress in all its forms, these communities provide support from others who have shared experience and learnings
We do not know the specifics of how he lost all of his weight, but within the first three months, he lost about 70 pounds
Patients taking Wegovy lost an average of 35 lbs compared to 6 lbs in the placebo group